(Q54331253)

27 May 2018

title

Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. (English)

1 reference

27 May 2018

0 references

1

1 reference

27 May 2018

author name string

Antonina Accardo-Palumbo

2

1 reference

27 May 2018

Riccardo Alessandro

3

1 reference

27 May 2018

Aroldo Rizzo

4

1 reference

27 May 2018

Simona Principe

5

1 reference

27 May 2018

Sergio Peralta

6

1 reference

27 May 2018

Francesca Raiata

7

1 reference

27 May 2018

Annarita Giardina

8

1 reference

27 May 2018

Giacomo De Leo

9

1 reference

27 May 2018

Giovanni Triolo

10

1 reference

27 May 2018

publication date

27 December 2011

1 reference

27 May 2018

published in

Arthritis and Rheumatism

1 reference

27 May 2018

volume

64

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

1869-1878

1 reference

27 May 2018

Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response.

cites work

1 reference

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.

21 January 2018

1 reference

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

21 January 2018

1 reference

Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells

21 January 2018

1 reference

Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin

21 January 2018

1 reference

RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells

21 January 2018

1 reference

Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense

21 January 2018

1 reference

Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

21 January 2018

1 reference

IL-22: a critical mediator in mucosal host defense

21 January 2018

1 reference

IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease.

21 January 2018

1 reference

Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice

21 January 2018

1 reference

Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A

21 January 2018

1 reference

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

21 January 2018

1 reference

IL-17 and IL-22: siblings, not twins.

21 January 2018

1 reference

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing

21 January 2018

1 reference

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

21 January 2018

1 reference

STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation

21 January 2018

1 reference

Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome.

21 January 2018

1 reference

Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

21 January 2018

1 reference

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

21 January 2018

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI33194

Identifiers

DOI

10.1002/ART.34355

1 reference

27 May 2018

1 reference

27 May 2018